Fair Value Measurement (Restated) (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
|---|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
5,180 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
5,180 |
|
Commercial paper |
|
|
— |
|
|
|
2,097 |
|
|
|
— |
|
|
|
2,097 |
|
|
|
$ |
5,180 |
|
|
$ |
2,097 |
|
|
$ |
— |
|
|
$ |
7,277 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
1,494 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,494 |
|
Corporate securities |
|
|
— |
|
|
|
7,745 |
|
|
|
— |
|
|
|
7,745 |
|
Commercial paper |
|
|
— |
|
|
|
2,576 |
|
|
|
— |
|
|
|
2,576 |
|
U.S. government and agency securities |
|
|
— |
|
|
|
11,269 |
|
|
|
— |
|
|
|
11,269 |
|
|
|
$ |
1,494 |
|
|
$ |
21,590 |
|
|
$ |
— |
|
|
$ |
23,084 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Public Warrants |
|
$ |
267 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
1,831 |
|
|
$ |
— |
|
|
$ |
1,831 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
349 |
|
|
|
349 |
|
|
|
$ |
— |
|
|
$ |
1,831 |
|
|
$ |
349 |
|
|
$ |
2,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 (1) |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Public Warrants |
|
$ |
5,060 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
5,060 |
|
Private Warrants |
|
|
— |
|
|
|
6,422 |
|
|
|
— |
|
|
|
6,422 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
10,026 |
|
|
|
10,026 |
|
|
|
$ |
5,060 |
|
|
$ |
6,422 |
|
|
$ |
10,026 |
|
|
$ |
21,508 |
|
(1) There were no cash equivalents or marketable securities as of December 31, 2021.
|
| Summary of Change in Fair Value of Level 3 Financial Instruments |
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
Contingent
Earnout
Liability |
|
|
Fair value as of December 31, 2021 |
|
|
10,026 |
|
|
Change in fair value of contingent earnout liability |
|
|
(9,677 |
) |
|
Fair value as of December 31, 2022 |
|
$ |
349 |
|
|
|
| Schedule of Cash and Cash Equivalents and Investments |
The following table summarizes the Company's cash, cash equivalents and available-for-sale securities by significant marketable securities category:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
39,919 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
39,919 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
5,180 |
|
|
|
— |
|
|
|
— |
|
|
|
5,180 |
|
Commercial paper |
|
|
2,098 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
2,097 |
|
|
|
$ |
47,197 |
|
|
$ |
— |
|
|
$ |
(1 |
) |
|
$ |
47,196 |
|
Marketable Securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
1,495 |
|
|
$ |
— |
|
|
$ |
(1 |
) |
|
$ |
1,494 |
|
Corporate securities |
|
|
7,771 |
|
|
|
— |
|
|
|
(26 |
) |
|
|
7,745 |
|
Commercial paper |
|
|
2,578 |
|
|
|
— |
|
|
|
(2 |
) |
|
|
2,576 |
|
U.S. government and agency securities |
|
|
11,272 |
|
|
|
— |
|
|
|
(3 |
) |
|
|
11,269 |
|
|
|
$ |
23,116 |
|
|
$ |
— |
|
|
$ |
(32 |
) |
|
$ |
23,084 |
|
|
| Amortized cost and estimated fair value of marketable securities |
The following table represents amortized cost and estimated fair value of marketable securities, by contractual maturity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
|
|
|
|
|
|
Amortized Cost |
|
|
Fair Value |
|
Due in one year or less |
|
|
|
|
|
$ |
23,116 |
|
|
$ |
23,084 |
|
|
| Private Warrants [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
The table below quantifies the significant inputs used for the Private Warrants:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Fair value of the Company’s Class A common stock |
|
$ |
— |
|
|
$ |
3.38 |
|
Exercise price |
|
$ |
— |
|
|
$ |
11.50 |
|
Risk-free interest rate |
|
|
— |
% |
|
|
1.26 |
% |
Expected volatility factor |
|
|
— |
% |
|
|
70.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Remaining contractual term (in years) |
|
|
— |
|
|
|
4.6 |
|
|
| Contingent Earnout Liability [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
The table below quantifies the significant inputs used for the contingent earnout liability:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Fair value of the Company’s Class A common stock |
|
$ |
0.96 |
|
|
$ |
3.38 |
|
Risk-free interest rate |
|
|
4.16 |
% |
|
|
1.26 |
% |
Expected volatility factor |
|
|
55.0 |
% |
|
|
70.0 |
% |
Earnout expiration date |
|
August 16, 2026 |
|
|
August 16, 2026 |
|
|
| Credit Agreement Warrants [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
The table below quantifies the significant inputs used for the Credit Agreement Warrants:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Fair value of the Company’s Class A common stock |
|
$ |
0.96 |
|
|
$ |
— |
|
Exercise price |
|
$ |
2.01 |
|
|
$ |
— |
|
Risk-free interest rate |
|
|
3.88 |
% |
|
|
— |
% |
Expected volatility factor |
|
|
55.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Remaining contractual term (in years) |
|
|
9.1 |
|
|
|
— |
|
|